Prostate-selective α antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: a nationwide population-based study

INTRODUCTIONS: Prostate-selective α antagonists are recommended for relief of lower urinary tract symptoms in prostate cancer patients despite uncertainty of fracture risk as an addition to androgen deprivation therapy (ADT). The purpose of this study is to estimate fracture risk associated with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Wei-Heng, Kuo, Chang-Fu, Chou, I-Jun, See, Lai-Chu, Huang, Wen-Kuan, Chiou, Meng-Jiun, Zhang, Weiya, Doherty, Michael, Wang, Chun-Chieh, Hsu, Jun-Te, Chen, Hsien-Hsin, Hong, Ji-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797048/
https://www.ncbi.nlm.nih.gov/pubmed/29435177
http://dx.doi.org/10.18632/oncotarget.23828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797048/
https://www.ncbi.nlm.nih.gov/pubmed/29435177
http://dx.doi.org/10.18632/oncotarget.23828

Ejemplares similares